Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Asymptomatic Reinfection in 2 Healthcare Workers From India With Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2.
Gupta V, Bhoyar RC, Jain A, Srivastava S, Upadhayay R, Imran M, Jolly B, Divakar MK, Sharma D, Sehgal P, Ranjan G, Gupta R, Scaria V, Sivasubbu S. Gupta V, et al. Among authors: srivastava s. Clin Infect Dis. 2021 Nov 2;73(9):e2823-e2825. doi: 10.1093/cid/ciaa1451. Clin Infect Dis. 2021. PMID: 32964927 Free PMC article. No abstract available.
A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial.
Srivastava A, Rengaraju M, Srivastava S, Narayan V, Gupta V, Upadhayay R. Srivastava A, et al. Among authors: srivastava s. Trials. 2021 Feb 11;22(1):130. doi: 10.1186/s13063-021-05041-x. Trials. 2021. PMID: 33573696 Free PMC article.
Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to moderate symptomatic COVID-19 patients-a double-blind, placebo-controlled, clinical trial.
Srivastava A, Rengaraju M, Srivastava S, Narayanan V, Gupta V, Upadhayay R, Kumar J, Parameswaran S, KanakavalliKadarkarai, AarthiVelmurugan. Srivastava A, et al. Among authors: srivastava s. Trials. 2021 Aug 28;22(1):570. doi: 10.1186/s13063-021-05478-0. Trials. 2021. PMID: 34454572 Free PMC article. Clinical Trial.
6,110 results